GPHN and Alzheimer disease: In a previous study, we observed increased immunoreactivity of the GABAergic postsynaptic marker gephyrin in perisomatic regions of the pyramidal cell layer (PCL) of the CA1 region of young (1- and 3-month-old) APPPS1 mice, possibly corresponding to early stages of cerebral amyloidosis in AD [4].